Profiles of Cytokines (TNFα and IL-6) and Acute Phase Proteins (CRP and α1AG) related to the Disease Course in Patients with Systemic Lupus Erythematosus

Abstract

Tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) play a main role in inducing acute phase protein production by hepatocytes. This study describes the serum levels of TNFα and IL-6 in relation to serum levels of C-reactive protein (CRP) and α1-acid glycoprotein (α1AG) in three systemic lupus erythematosus (SLE) patients. Disease courses of these patients were divided in a total of 19 clinical periods, according to the clinical symptoms and interleukine profiles. Significantly elevated TNFα levels were found in all but three of the defined periods, without being associated with disease activity. In only four of the defined periods elevated TNFα were observed combined with elevated IL-6 and CRP levels. Two of these periods coincided with minor symptoms of SLE, one with an exacerbation and the other one with a systemic infection while SLE activity was low. All other periods showed varying combinations of elevated TNFα and/or IL-6 levels being followed or not by elevated CRP levels. Significantly raised α1AG levels were measured in all clinical periods. In most of the observed periods a dissociation was found between TNFα and IL-6 and also between the different cytokine (TNFα and IL-6) levels and acute phase protein (CRP and α1AG) levels. These data could not be explained by differences in disease course or influences of medication. We conclude that more factors other than TNFα and IL-6 must play a role in the regulatory pathway of the acute phase response in SLE. These data are also highly suggestive of an imbalance between TNF, IL-6 and the acute phase reaction.

Keywords

TNFα IL-6 CRP α1AG

Get full access to this article

View all access options for this article.

References

Castell JV , Gómez-Lechón MJ , David M. et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-9.

Castell JV , Gómez-Lechón MJ , David M. , Fabra R. , Trullenque R. , Heinrich PC Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin-6. Hepatology 1990 ; 12:1179-86.

Emergy P. , Saljon M. Systemic mediators of inflammation. Br J Hosp Med 1991; 45:164-8.

Swaak Ajg , Rooyen A van , Nieuwenhuis F. , Aarden LA Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988 ; 17: 469-74.

Swaak Ajg , Rooijen A van , Aarden LA Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int 1989; 8: 263-8.

Swaak Ajg , Sintnicolaas C. , Meijer C. , Smeenk RT Observations on the interleukin-6 and acute phase protein profiles in the disease course of patients with lupus erythematosus. Lupus 1992; 1: 151-5.

Linker-Israeli M. , Deans RJ , Wallace DJ , Prehn J. , Ozeri-Chen T. , Klinenberg JR Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147: 117-23.

Pepys MB C-reactive protein fifty years on. Lancet 1981; i: 653-7.

Becker GJ , Waldburger M. , Hughes Grv , Pepys MB Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980; 39: 50-2.

10.

Morrow Wjw , Isenberg DA , Parry HF , Snaith ML C-Reactive protein in sera from patients with systemic lupus erythematosus . J Rheumatol 1981; 8: 599-604.

11.

Maury Cpj. Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol 1989; 43: 1078-82.

12.

Maury Cpj , Teppo AM Tumor necrosis factor in the serum of patients with systemic lupus erythematosus . Arthritis Rheum 1989; 32: 146-50.

13.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.

14.

Swaak Ajg , Aarden LA , Statius van Eps WL, Feltkamp TEW. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 226-35.

15.

Swaak Ajg , Groenwold J. , Bronsveld W. The predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 359-66.

16.

Kooten C van , Rensink I. , Pascual-Salcedo D. , Oers R van, Aarden L. Monokine production by human T cells; IL-1α production restricted to memory T cells. J Immunol 1991 ; 146: 2654-8.

17.

Aarden LA , Helle M. , Groot ER de , Brakenhoff Jpj. Relation between hybridoma factor and IL-1. In: Meechers F , Potter M , (eds), Mechanisms of B Cell Neoplasia. Springer, Berlin, Heidelberg, new York , 1989, pp. 101-5.

18.

Brakenhoff Jpj , Groot ER de , Evers RF , Pannekoek H. , Aarden LA Molecular cloning and expression of hybridoma growth factor in E. coli. J Immunol 1987; 139: 4116-21.

19.

Oers MHJ, Heijden AAPAM van der, Aarden LA. Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 314-19.

20.

Nysten Mwn , Groot ER de , Duis HJ ten , Klasen HJ , Hack CE , Aarden LA Serum levels of Interleukin-6 and acute phase response. Lancet 1987; ii: 921.

21.

Murata A. , Ogawa M. , Yasuda T. et al. Serum interleukin-6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery. Immunol Invest 1990; 19: 271-8.

22.

Pullicino EA , Carli F. , Poole S. , Rafferty B. , Malik ST , Elia M. The relationship between the circulating concentrations of Interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental surgery. Lymphokine Res 1990; 9: 231-8.

23.

Zein N. , Ganuza C. , Kishner I. Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum 1979; 22: 7-12.

24.

Bertouch JV , Roberts-Thompson PJ , Feng PH , Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus . Ann Rheum Dis 1983; 42: 655-8.

25.

Waage A. , Halstensen A. , Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i: 355-7.

26.

Scuderi P. , Sterling KE , Lam KS et al. Raised serum levels of tumour necrosis factor in parasitic infections . Lancet 1986; ii: 1364-5.

27.

Jablons DM , Mule JJ , McIntos JK et al. IL-6/IFN-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989; 142: 1542-7.

28.

McIntosh JJ , Jablons DM , Mule JJ et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of the novo serum levels of IL-6 in tumor-bearing mice. J Immunol 1989; 143: 162-7.